EP 3021846 A1 20160525 - COMBINATIONS COMPRISING TRICYCLOHEXADECAHEXAENE DERIVATIVES FOR USE IN THE TREATMENT OF HEPATITIS C VIRUS
Title (en)
COMBINATIONS COMPRISING TRICYCLOHEXADECAHEXAENE DERIVATIVES FOR USE IN THE TREATMENT OF HEPATITIS C VIRUS
Title (de)
KOMBINATIONEN MIT TRICYCLOHEXADECAHEXAENDERIVATEN ZUR BEHANDLUNG VON HEPATITIS-C-VIRUS
Title (fr)
ASSOCIATIONS COMPRENANT DES DÉRIVÉS DU TRICYCLOHEXADÉCAHEXAÈNE DESTINÉES À ÊTRE UTILISÉES POUR LE TRAITEMENT DU VIRUS DE L'HÉPATITE C
Publication
Application
Priority
- US 201361847388 P 20130717
- US 2014046685 W 20140715
Abstract (en)
[origin: WO2015026454A1] The present disclosure is generally directed to antiviral compounds, and more specifically directed to combinations of compounds which can inhibit the function of the NS5A protein encoded by Hepatitis C virus (HCV), compositions comprising such combinations, and methods for inhibiting the function of the NS5A protein.
IPC 8 full level
A61K 31/4164 (2006.01); A61K 31/4178 (2006.01); A61K 31/4184 (2006.01); A61P 31/14 (2006.01); C07D 235/04 (2006.01)
CPC (source: EP)
A61K 31/4178 (2013.01); A61K 31/4184 (2013.01); A61K 31/7056 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); A61P 1/16 (2017.12); A61P 31/14 (2017.12); A61P 43/00 (2017.12); C07D 403/10 (2013.01)
Citation (search report)
See references of WO 2015026454A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2015026454 A1 20150226; CN 105555266 A 20160504; CN 105555266 B 20181130; EP 3021846 A1 20160525; JP 2016525114 A 20160822
DOCDB simple family (application)
US 2014046685 W 20140715; CN 201480050770 A 20140715; EP 14748036 A 20140715; JP 2016527033 A 20140715